300485 賽升藥業
按盤價 
6.290 +0.110 (+1.780%)
6.290 +0.110 (+1.780%) | 2024/03 - 三個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -5.706 | 3.023 | 6.187 | 13.300 | 5.655 |
| 總資產報酬率 ROA (%) | -5.421 | 2.862 | 5.874 | 12.585 | 5.345 |
| 投入資產回報率 ROIC (%) | -5.554 | 2.936 | 6.064 | 13.172 | 5.632 | 邊際利潤分析 |
| 銷售毛利率 (%) | 66.074 | 70.426 | 76.638 | 82.668 | 83.793 |
| 營業利潤率 (%) | -205.449 | 25.544 | 34.666 | 41.777 | 16.442 |
| 息稅前利潤/營業總收入 (%) | -205.678 | 25.414 | 34.602 | 40.704 | 15.169 |
| 淨利潤/營業總收入 (%) | -175.602 | 20.230 | 27.588 | 37.603 | 13.826 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | -2.490 | -33.626 | 9.430 | 24.096 | 81.100 |
| 價值變動淨收益/利潤總額(%) | 102.696 | 131.033 | 83.309 | 72.533 | 22.865 |
| 營業外收支淨額/利潤總額(%) | 0.000 | 0.349 | -0.008 | 0.006 | -0.349 | 償債能力分析 |
| 流動比率 (X) | 20.877 | 26.300 | 17.621 | 17.298 | 10.932 |
| 速動比率 (X) | 19.261 | 24.219 | 16.432 | 15.907 | 9.763 |
| 資產負債率 (%) | 3.957 | 4.268 | 4.402 | 3.485 | 0.047 |
| 帶息債務/全部投入資本 (%) | 0.154 | 0.172 | 0.253 | 0.374 | 0.384 |
| 股東權益/帶息債務 (%) | 63,362.179 | 56,495.613 | 38,469.304 | 26,389.748 | 25,901.404 |
| 股東權益/負債合計 (%) | 2,405.070 | 2,222.370 | 2,147.677 | 2,737.166 | 1,987.146 |
| 利息保障倍數 (X) | 900.911 | -115.483 | -563.178 | -37.840 | -12.469 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 39.220 | 46.431 | 40.964 | 35.355 | 44.262 |
| 存貨周轉天數 (天) | 260.986 | 250.518 | 222.522 | 278.408 | 333.736 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 02/07/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
